Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2574]

ESMO 2025: Drug combo cuts risk of death in advanced prostate cancer by 40%

ESMO 2025: Drug combo cuts risk of death in advanced prostate cancer by 40%

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer

ESMO 2025: Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening - ICR

ESMO 2025: Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening - ICR

New imaging solution could help improve survival for patients with recurring prostate cancer

New imaging solution could help improve survival for patients with recurring prostate cancer

Short-course radiation therapy after prostate surgery helps keep cancer from returning

Short-course radiation therapy after prostate surgery helps keep cancer from returning

Why cancer immunotherapy fails: Researchers link it to protein quality control collapse

Why cancer immunotherapy fails: Researchers link it to protein quality control collapse

Kidney cancer cases are projected to double by 2050, says study

Kidney cancer cases are projected to double by 2050, says study

ASTRO 2025: New therapy delays progression of recurrent prostate cancer

ASTRO 2025: New therapy delays progression of recurrent prostate cancer

Study finds most cancer patients exposed to misinformation. Researchers pilot 'information prescription.'

Study finds most cancer patients exposed to misinformation. Researchers pilot 'information prescription.'

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

More from ecancer